Viatris Aurangabad facility gets Global Minimized Risk of Antimicrobial Resistance Certification

“Viatris having gained independent certification, and the first to do so in India, is a reflection of their leadership and commitment to tackling global AMR,” said Steve Brooks, Advisor and Manufacturing Work Group Lead, AMR Industry Alliance. “From their initial days with the Alliance, Viatris has been a key contributor to achieving greater results in our shared goal of providing sustainable solutions to curb AMR while being responsible stewards of the environment.”

AMR is recognized around the world as a significant threat to global health and economic development and is a major driver of death globally. Recent research shows that in 2019, more than 1.2 million people are estimated to have died directly from antibiotic-resistant bacterial infections. By 2050, it is estimated that AMR will cause more deaths than cancer unless concerted efforts are undertaken to counter its progression.

Read also: Biocon arm completes integration of Viatris biosimilars business in 120 countries